These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
537 related items for PubMed ID: 27044381
1. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A. Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381 [Abstract] [Full Text] [Related]
2. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Rapti SM, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481 [Abstract] [Full Text] [Related]
3. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients. Diamantopoulos MA, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A. Clin Chem Lab Med; 2017 May 01; 55(5):737-747. PubMed ID: 27930363 [Abstract] [Full Text] [Related]
4. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A. Clin Chem Lab Med; 2014 Aug 01; 52(8):1217-27. PubMed ID: 24615484 [Abstract] [Full Text] [Related]
5. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. Clin Biochem; 2017 Apr 01; 50(6):285-292. PubMed ID: 27939727 [Abstract] [Full Text] [Related]
6. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma. Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A. Mol Diagn Ther; 2017 Aug 01; 21(4):453-464. PubMed ID: 28405803 [Abstract] [Full Text] [Related]
7. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease. Tsiakanikas P, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A. Clin Chem Lab Med; 2018 May 24; 56(6):990-1000. PubMed ID: 29688883 [Abstract] [Full Text] [Related]
8. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Adamopoulos PG, Kontos CK, Rapti SM, Papadopoulos IN, Scorilas A. Int J Oncol; 2015 Feb 24; 46(2):849-59. PubMed ID: 25420464 [Abstract] [Full Text] [Related]
9. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Yuan D, Li K, Zhu K, Yan R, Dang C. Cancer Biol Ther; 2015 Feb 24; 16(2):268-75. PubMed ID: 25629978 [Abstract] [Full Text] [Related]
10. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y. Eur J Gastroenterol Hepatol; 2014 Feb 24; 26(2):229-33. PubMed ID: 24150523 [Abstract] [Full Text] [Related]
11. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Luo M, Shen D, Wang W, Xian J. Int J Clin Exp Pathol; 2015 Feb 24; 8(5):5542-8. PubMed ID: 26191262 [Abstract] [Full Text] [Related]
13. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX. World J Gastroenterol; 2014 Aug 28; 20(32):11340-6. PubMed ID: 25170220 [Abstract] [Full Text] [Related]
14. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer. Jiang H, Liu J, Chen Y, Ma C, Li B, Hao T. Cancer Med; 2016 Oct 28; 5(10):2932-2941. PubMed ID: 27592860 [Abstract] [Full Text] [Related]
15. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y. Int J Clin Exp Pathol; 2015 Oct 28; 8(7):8394-401. PubMed ID: 26339409 [Abstract] [Full Text] [Related]
16. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X. Biomed Pharmacother; 2015 Oct 28; 75():153-8. PubMed ID: 26422796 [Abstract] [Full Text] [Related]
17. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK. Mol Carcinog; 2014 Feb 28; 53 Suppl 1():E36-44. PubMed ID: 24009195 [Abstract] [Full Text] [Related]
18. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Lv ZC, Fan YS, Chen HB, Zhao DW. Tumour Biol; 2015 Mar 28; 36(3):1619-25. PubMed ID: 25528214 [Abstract] [Full Text] [Related]
19. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S, Yi XM, Zhou WQ, Cheng W, Ge JP, Zhang ZY. Int J Clin Exp Pathol; 2015 Mar 28; 8(11):14335-44. PubMed ID: 26823749 [Abstract] [Full Text] [Related]
20. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma. Kalioraki MA, Artemaki PI, Sklirou AD, Kontos CK, Adamopoulos PG, Papadopoulos IN, Trougakos IP, Scorilas A. Mol Carcinog; 2020 Jan 28; 59(1):116-125. PubMed ID: 31709619 [Abstract] [Full Text] [Related] Page: [Next] [New Search]